中国卒中杂志 ›› 2024, Vol. 19 ›› Issue (12): 1448-1453.DOI: 10.3969/j.issn.1673-5765.2024.12.012

• 论著 • 上一篇    下一篇

系统性免疫炎症指数、C反应蛋白/白蛋白比值对急性缺血性卒中患者溶栓后短期预后的评估价值

刘晓梅,苟重季,付丽   

  1. 彭州 611930 彭州市人民医院神经内科
  • 收稿日期:2023-08-02 出版日期:2024-12-20 发布日期:2024-12-20
  • 通讯作者: 刘晓梅 Lxm53575@126.com
  • 基金资助:
    四川省青年创新项目(H2022007)

Evaluation Value of Systemic Immune-Inflammation Index and C-Reactive Protein/Albumin Ratio in Short-Term Prognosis of Patients with Acute Ischemic Stroke after Thrombolytic Therapy

LIU Xiaomei, GOU Zhongji, FU Li   

  1. Department of Neurology, The People’s Hospital of Pengzhou, Pengzhou 611930, China
  • Received:2023-08-02 Online:2024-12-20 Published:2024-12-20
  • Contact: LIU Xiaomei, E-mail: Lxm53575@126.com

摘要: 目的 探讨系统性免疫炎症指数(systemic immune-inflammation index,SII)、CRP/白蛋白(albumin,ALB)对接受rt-PA溶栓治疗的急性缺血性卒中(acute ischemic stroke,AIS)患者短期预后的预测作用。
方法 回顾性分析彭州市人民医院2022年1—12月收治的接受rt-PA溶栓治疗的AIS患者临床病例资料。采用mRS评估患者发病后30 d预后情况,mRS评分≤2分为预后良好,mRS评分>3分为预后不良。采集入院时外周血检验结果计算SII和CRP/ALB。单因素和logistic多因素分析AIS患者预后的影响因素。采用ROC曲线分析SII、CRP/ALB对AIS患者预后的预测作用。
结果 本研究共纳入134例AIS患者,其中预后不良者29例(21.64%)。单因素分析发现,预后不良患者入院时NIHSS评分、血小板计数、D-二聚体、凝血酶原时间、TC、CRP、SII、CRP/ALB高于预后良好患者,差异有统计学意义(P<0.05);预后不良患者淋巴细胞计数、ALB低于预后良好患者,差异有统计学意义(P<0.05)。logistic多因素分析显示入院时NIHSS评分(OR 19.028,95%CI 2.785~27.348,P<0.001)、TC(OR 6.979,95%CI 1.851~12.191,P=0.009)、CRP(OR 7.830,95%CI 2.559~14.252,P=0.002)、ALB(OR 0.192,95%CI 0.101~0.662,P<0.001)、SII(OR 9.244,95%CI 2.571~19.379,P<0.001)、CRP/ALB(OR 11.100,95%CI 3.570~22.451,P<0.001)是患者预后不良的独立影响因素。ROC曲线分析显示SII、CRP/ALB对预后不良具有预测价值,AUC分别为0.648(95%CI 0.529~0.767,P=0.015)和0.749(95%CI 0.664~0.883,P<0.001),敏感度分别为0.448、0.931,特异度分别为0.876、0.562。
结论 SII和CRP/ALB是患者预后不良的独立影响因素,联合SII、CRP/ALB评估,有助于早期识别高危AIS患者。

文章导读: 本研究通过回顾性分析发现SII和CRP/ALB是急性缺血性卒中患者溶栓后短期预后不良的影响因素,对预后评估具有一定价值。

关键词: 急性缺血性卒中; 系统性免疫炎症指数; C反应蛋白/白蛋白; 溶栓; 阿替普酶; 预后

Abstract: Objective  To investigate the predictive effects of systemic immune-inflammation index (SII) and CRP/albumin (ALB) on short-term prognosis of acute ischemic stroke (AIS) patients receiving thrombolytic therapy with rt-PA. 
Methods  The clinical data of AIS patients who received rt-PA thrombolytic therapy in The People’s Hospital of Pengzhou from January to December 2022 were retrospectively analyzed. The mRS was used to evaluate the prognosis of patients 30 days after the onset of the disease. The mRS score of≤2 points was considered a good prognosis, while mRS score>3 points was considered a poor prognosis. SII and CRP/ALB were calculated from peripheral blood test results at admission. The factors influencing prognosis of AIS patients were analyzed by univariate and logistic multivariate analysis. The predictive effects of SII and CRP/ALB on the prognosis of AIS patients were analyzed using the ROC curve. 
Results  A total of 134 AIS patients were included in this study, of which 29 patients (21.64%) had poor prognosis. Univariate analysis showed that NIHSS score, platelet count, D-dimer, prothrombin time, TC, CRP, SII, and CRP/ALB in patients with poor prognosis were higher than those with good prognosis, and the differences were statistically significant (P<0.05). The lymphocyte count and ALB in patients with poor prognosis were lower than those with good prognosis, and the differences were statistically significant (P<0.05). Logistic multivariate analysis showed that NIHSS score (OR 19.028, 95%CI 2.785-27.348, P<0.001), TC (OR 6.979, 95%CI 1.851-12.191, P=0.009), CRP (OR 7.830, 95%CI 2.559-14.252, P=0.002), ALB (OR 0.192, 95%CI 0.101-0.662, P<0.001), SII (OR 9.244, 95%CI 2.571-19.379, P<0.001), and CRP/ALB (OR 11.100, 95%CI 3.570-22.451, P<0.001) were independent influencing factors of poor prognosis. ROC curve analysis showed that SII and CRP/ALB had predictive value for poor prognosis, with AUC of 0.648 (95%CI 0.529-0.767, P=0.015) and 0.749 (95%CI 0.664-0.883, P<0.001), sensitivity of 0.448 and 0.931, and specificity of 0.876 and 0.562, respectively. 
Conclusions  SII and CRP/ALB are independent influencing factors for poor prognosis of patients, and combined assessment of SII and CRP/ALB is helpful for early identification of high-risk AIS patients. 

Key words: Acute ischemic stroke; Systemic immune-inflammation index; C-reactive protein/albumin; Thrombolysis; Alteplase; Prognosis

中图分类号: